Proteinea employs proprietary AI models and computational tools to engineer next-gen antibodies with improved efficacy, safety and convenience
We specialize in rational engineering of antibody Fc domains to enable context-specific immune tuning, enhanced half-life, and targeted biodistribution. Our proprietary design frameworks combine AI-driven prediction with therapeutic insight to unlock differentiated immune function.
Our Fc-optimized scaffolds are built with translation in mind. We integrate manufacturability, stability, pharmacokinetics, and delivery considerations directly into the design process, reducing downstream failure and accelerating path-to-patient.
Our experimental workflows are tailored to rapidly test Fc designs for function and developability. With smart wet-lab validation, we bridge computational design to biological reality using minimal experimental data and maximal insight.